Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

Clinical trial NCT00618748 · COMPLETED

Trial details

NCT number: NCT00618748
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2008-02-01
Primary completion: 2010-09-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.